Dr. Reddy's Laboratories (DRREDDY) — Financial Results

Dr. Reddy's Laboratories Limited filed unaudited Q2 and H1 FY2026 financial results (ended September 30, 2025) approved by the Board on October 24, 2025, as required under SEBI Listing Obligations Regulation 47. Results were published in Financial Express and Andhra Prabha. However, the actual financial figures (revenue, net profit, margins) are not clearly visible in the available document sections due to formatting and encoding issues. The filing confirms regulatory compliance with mandatory newspaper publication.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DRREDDY ✨ Ask AI About This

About Dr. Reddy's Laboratories Limited (DRREDDY)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,11,568.6 Cr P/E: 20.0 ROE: 16.6% ROCE: 19.7%

View full DRREDDY stock details →

📡 Get AI alerts when DRREDDY files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DRREDDY — Free

💡 Ask AI about this filing

"How does this financial results affect Dr. Reddy's Laboratories Limited's outlook?" "What did Dr. Reddy's Laboratories Limited announce on 25 October 2025?" "Is this positive or negative for DRREDDY?"

Ask AI Free →

📊 More DRREDDY filings

See all DRREDDY filings →

🔥 Also filed on 25 October 2025

KOTAKBANK Kotak Mahindra Bank Limited Financial Results SBICARD SBI Cards and Payment Services Limited Financial Results KOTAKBANK Kotak Mahindra Bank Limited Financial Results RELIANCE Reliance Industries Limited Related Party Transaction KOTAKBANK Kotak Mahindra Bank Limited Board Meeting LICI Life Insurance Corporation Of India Board Meeting

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DRREDDY files new disclosures

Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.